日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

突变型 KRAS 疫苗联合双重检查点阻断治疗切除的胰腺癌:一项 I 期试验。

Huff Amanda L, Haldar S Daniel, Gergis Alexander A, Wang Hejia Henry, Danilova Ludmila, Heumann Thatcher, Berg Maureen, Wang Yuxuan, Andaloori Lalitya, Hernandez Alexei, Longway Gabriella, Barrett Benjamin, Zhu Zirui, Davis-Marcisak Emily, Thoburn Christopher, Leatherman James, Mitchell Sarah, Lee Jae W, Shu Daniel H, Konig Maximillian F, Mog Brian J, Montagne Janelle, Coyne Erin M, Bever Katherine, Baretti Marina, Yarchoan Mark, Anders Robert A, Kagohara Luciane T, Laheru Daniel, Thomas Amy M, Durham Jennifer, Nauroth Julie M, Lu Jiayun, Wang Hao, Fertig Elana J, Ho Won Jin, Azad Nilofer S, Jaffee Elizabeth M, Zaidi Neeha

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

针对TP53突变相关新抗原的双特异性抗体和CAR T细胞表现出不一致的亲和力要求。

DiNapoli Sarah R, Wright Katharine M, Mog Brian J, Pearlman Alexander H, Nichakawade Tushar D, Marcou Nikita, Hsiue Emily Han-Chung, Hwang Michael S, Douglass Jacqueline, Liu Qiang, Watson Evangeline, Dal Molin Marco, Cohen Joshua D, Popoli Maria, Paul Suman, Konig Maximilian F, Wyhs Nicolas, Azurmendi P Aitana, Glavaris Stephanie, Ge Jiaxin, Awosika Tolulope O, Liu Jin, Gabrielson Kathleen L, Gabelli Sandra B, Pardoll Drew M, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Zhou Shibin, Vogelstein Bert

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

靶向 TRBC2 的抗体药物偶联物用于治疗 T 细胞癌。

Ge Jiaxin, Urban Joshua, DiNapoli Sarah R, Lee Bum Seok, Ahmedna Taha, Nichakawade Tushar D, Mog Brian J, Lu Steve, Li Xuyang, Marcou Nikita, Glavaris Stephanie, Douglass Jacqueline, Liu Jin, Konig Maximilian F, Watson Evangeline, Popoli Maria, Peske J David, Rozati Sima, Sterling Cole H, Wagner-Johnston Nina, Ambinder Richard F, Gabrielson Kathy, Mullighan Charles G, Papadopoulos Nickolas, Bettegowda Chetan, Pardoll Drew M, Zhou Shibin, Sur Surojit, Kinzler Kenneth W, Vogelstein Bert, Paul Suman

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells.

利用抗9G4特异性合成免疫受体T细胞精确靶向系统性红斑狼疮中的自身反应性B细胞。

Liu Jin, Xia Yuanxuan, Mog Brian J, Gliech Colin, Shaw Elana, Ferris Dylan, Moritz Brock, Awosika Tolulope O, DiNapoli Sarah R, Glavaris Stephanie, Kaeo Kyle J, Li Xuyang, Marcou Nikita, Pearlman Alexander H, Ahmedna Taha S, Bugrovsky Regina, Sanz Iñaki, Bettegowda Chetan, Paul Suman, Alvarado Victoria Duarte, Wirtz Denis, Goldman Daniel, Petri Michelle, Kinzler Kenneth W, Zhou Shibin, Andrade Felipe, Vogelstein Bert, Konig Maximilian F

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

临床前研究表明,Co-STARs 结合了嵌合抗原和 T 细胞受体的优势,可用于治疗抗原密度低的肿瘤

Mog Brian J, Marcou Nikita, DiNapoli Sarah R, Pearlman Alexander H, Nichakawade Tushar D, Hwang Michael S, Douglass Jacqueline, Hsiue Emily Han-Chung, Glavaris Stephanie, Wright Katharine M, Konig Maximilian F, Paul Suman, Wyhs Nicolas, Ge Jiaxin, Miller Michelle S, Azurmendi P, Watson Evangeline, Pardoll Drew M, Gabelli Sandra B, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Zhou Shibin

Targeting public neoantigens for cancer immunotherapy

靶向公共新抗原进行癌症免疫治疗

Pearlman, Alexander H; Hwang, Michael S; Konig, Maximilian F; Hsiue, Emily Han-Chung; Douglass, Jacqueline; DiNapoli, Sarah R; Mog, Brian J; Bettegowda, Chetan; Pardoll, Drew M; Gabelli, Sandra B; Papadopoulos, Nicholas; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin

Author Correction: Targeting public neoantigens for cancer immunotherapy

作者更正:靶向公共新抗原进行癌症免疫治疗

Pearlman, Alexander H; Hwang, Michael S; Konig, Maximilian F; Hsiue, Emily Han-Chung; Douglass, Jacqueline; DiNapoli, Sarah R; Mog, Brian J; Bettegowda, Chetan; Pardoll, Drew M; Gabelli, Sandra B; Papadopoulos, Nicholas; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin